A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome

Wiernik, 1992, Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia, Blood, 79, 313, 10.1182/blood.V79.2.313.313 Herzig, 1985, High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia, J Clin Oncol., 3, 992, 10.1200/JCO.1985.3.7.992 Forman, 1991, Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia, J Clin Oncol., 9, 1570, 10.1200/JCO.1991.9.9.1570 Biggs, 1992, Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy, Blood, 80, 1090, 10.1182/blood.V80.4.1090.bloodjournal8041090 Michallet, 2000, Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia, Bone Marrow Transplant, 26, 1157, 10.1038/sj.bmt.1702690 Slovak, 2000, Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia, Blood, 96, 4075, 10.1182/blood.V96.13.4075 Chao, 2000, Equivalence of 2 effective graft-versus-host disease prophylaxis regimens, Biol Blood Marrow Transplant, 6, 254, 10.1016/S1083-8791(00)70007-3 Ross, 1999, Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease, Biol Blood Marrow Transplant, 5, 285, 10.1016/S1083-8791(99)70003-0 Appelbaum, 1983, Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse, Blood, 61, 949, 10.1182/blood.V61.5.949.949 Buckner, 1982, Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission, Leuk Res., 6, 395, 10.1016/0145-2126(82)90103-5 Mehta, 1994, Bone marrow transplantation for primary refractory acute leukaemia, Bone Marrow Transplant, 14, 415 Snyder, 1993, Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission, Blood, 82, 2920, 10.1182/blood.V82.9.2920.2920 Fung, 1999, Allogeneic bone marrow transplantation for acute myelogenous leukemia in first remission utilizing FTBI and VP-16, Blood, 94, 167a Schiller, 1994, Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors, Br J Haematol., 88, 72, 10.1111/j.1365-2141.1994.tb04979.x Sierra, 2000, Unrelated donor marrow transplantation for acute myeloid leukemia, Bone Marrow Transplant, 26, 397, 10.1038/sj.bmt.1702519 Hansen, 1998, Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia, N Engl J Med., 338, 962, 10.1056/NEJM199804023381405 Stein, 1998, Phase I-II study of escalating doses of busulfan in combination with fractionated total body irradiation and etoposide as a preparative regimen for allogeneic bone marrow transplantation for patients with advanced leukemias, Blood, 92, 517a Sievers, 1999, Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy, Blood, 93, 3678, 10.1182/blood.V93.11.3678 Matthews, 1997, The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies, Cancer Treat Res., 77, 121, 10.1007/978-1-4615-6349-5_6